Showing 1 - 10 of 65
Persistent link: https://www.econbiz.de/10011938004
We use data from PubMed and other sources to examine the impact of public and private research support on premature (before ages 75, 65, and 55) cancer mortality and hospitalization, by estimating difference-in-differences models based on longitudinal, cancer-site-level data on about 30 cancer...
Persistent link: https://www.econbiz.de/10012960774
Persistent link: https://www.econbiz.de/10011635206
The estimates indicate that cancer sites about which more research-supported articles were published since the 1970s had larger reductions in premature mortality and hospitalization during the period 1999-2013, controlling for the change in the number of people diagnosed. Cancer sites for which...
Persistent link: https://www.econbiz.de/10012455440
Persistent link: https://www.econbiz.de/10011964261
Persistent link: https://www.econbiz.de/10010407486
I analyze the effects of four types of medical innovation and cancer incidence on US cancer mortality rates during the … pre‐dated factors that drove both innovation and mortality and that there would have been parallel trends in mortality in … the absence of innovation, the estimates indicate that there were three major sources of the 13.8% decline of the age …
Persistent link: https://www.econbiz.de/10010466909
Persistent link: https://www.econbiz.de/10011701670
Persistent link: https://www.econbiz.de/10013556762
Assessing the benefits of medical innovation—its impact on health outcomes—is as important as assessing the costs … that investigates the benefits and costs of another broad category of medical innovation—inpatient therapeutic procedure … innovation—using data on over one million hospital discharges. …
Persistent link: https://www.econbiz.de/10011042743